Mount Yale Investment Advisors »

Cognition Therapeutics shares owned by Mount Yale Investment Advisors

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Mount Yale Investment Advisors from 13F filings

Historical chart of Mount Yale Investment Advisors investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Mount Yale Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Mount Yale Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.6k 10k 0.76

More positions owned by Mount Yale Investment Advisors

Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
JPMorgan Chase & Co. (JPM)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Home Depot (HD)

View all positions for Mount Yale Investment Advisors

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Vanguard Capital Management
Davenport & Co
Chescapmanager
Renaissance Technologies
BlackRock
Geode Capital Management
Hilton Capital Management
Dauntless Investment Group
Vanguard Fiduciary Trust
CM Management
Jane Street
Sigma Planning
State Street Corporation

View all funds holding Cognition Therapeutics